Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580

Patrick A. Eyers, Paul Van Den Ijssel, Roy A. Quinlan, Michel Goedert, Philip Cohen (Lead / Corresponding author)

    Research output: Contribution to journalArticlepeer-review

    101 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580'. Together they form a unique fingerprint.

    Keyphrases

    Neuroscience

    Pharmacology, Toxicology and Pharmaceutical Science

    Biochemistry, Genetics and Molecular Biology